The role of protein post-translational modifications in prostate cancer

被引:1
作者
Hao, Yinghui [1 ]
Gu, Chenqiong [1 ]
Luo, Wenfeng [1 ]
Shen, Jian [1 ]
Xie, Fangmei [1 ]
Zhao, Ying [1 ]
Song, Xiaoyu [1 ]
Han, Zeping [1 ]
He, Jinhua [1 ,2 ]
机构
[1] Guangzhou Med Univ, Affiliated Guangzhou Panyu Cent Hosp, Cent Lab, Guangzhou, Peoples R China
[2] Rehabil Med Inst Panyu Dist, Guangzhou, Guangdong, Peoples R China
来源
PEERJ | 2024年 / 12卷
关键词
Protein post-translational modification; Prostate cancer; Diagnosis; Treatment; Prognosis; DOCETAXEL RESISTANCE; DIAGNOSIS; GLYCOSYLATION; EXPRESSION; PATHWAY; PHOSPHORYLATION; TRANSCRIPTION; PROGRESSION; SUPPRESSES; BIOMARKER;
D O I
10.7717/peerj.17768
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Involving addition of chemical groups or protein units to specific residues of the target protein, post-translational modifications (PTMs) alter the charge, hydrophobicity, and conformation of a protein, which in turn influences protein function, protein-protein interaction, and protein aggregation. These alterations, which include phosphorylation, glycosylation, ubiquitination, methylation, acetylation, lipidation, and lactylation, are significant biological events in the development of cancer, and play vital roles in numerous biological processes. The processes behind essential functions, the screening of clinical illness signs, and the identification of therapeutic targets all depend heavily on further research into the PTMs. This review outlines the influence of several PTM types on prostate cancer (PCa) diagnosis, therapy, and prognosis in an effort to shed fresh light on the molecular causes and progression of the disease.
引用
收藏
页数:28
相关论文
共 148 条
[1]   Decoding the PTM-switchboard of Notch [J].
Antfolk, Daniel ;
Antila, Christian ;
Kemppainen, Kati ;
Landor, Sebastian K. -J. ;
Sahlgren, Cecilia .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2019, 1866 (12)
[2]   The path forward in prostate cancer therapeutics [J].
Aragon-Ching, Jeanny B. ;
Madan, Ravi A. .
ASIAN JOURNAL OF ANDROLOGY, 2018, 20 (03) :213-214
[3]   The expression and functional analysis of the sialyl-T antigen in prostate cancer [J].
Bai, Ruifeng ;
Luan, Xue ;
Zhang, Yu ;
Robbe-Masselot, Catherine ;
Brockhausen, Inka ;
Gao, Yin .
GLYCOCONJUGATE JOURNAL, 2020, 37 (04) :423-433
[4]   H3K9 methylation drives resistance to androgen receptor-antagonist therapy in prostate cancer [J].
Baratchian, Mehdi ;
Tiwari, Ritika ;
Khalighi, Sirvan ;
Chakravarthy, Ankur ;
Yuan, Wei ;
Berk, Michael ;
Li, Jianneng ;
Guerinot, Amy ;
de Bono, Johann ;
Makarov, Vladimir ;
Chan, Timothy A. ;
Silverman, Robert H. ;
Stark, George R. ;
Varadan, Vinay ;
De Carvalho, Daniel D. ;
Chakraborty, Abhishek A. ;
Sharifi, Nima .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (21)
[5]   Recent Advances and Current Role of Transperineal Prostate Biopsy [J].
Bhanji, Yasin ;
Allaway, Mathew J. ;
Gorin, Michael A. .
UROLOGIC CLINICS OF NORTH AMERICA, 2021, 48 (01) :25-33
[6]   Glycosylation Changes in Prostate Cancer Progression [J].
Butler, William ;
Huang, Jiaoti .
FRONTIERS IN ONCOLOGY, 2021, 11
[7]   Hypoxia-Inducible PIM Kinase Expression Promotes Resistance to Antiangiogenic Agents [J].
Casillas, Andrea L. ;
Toth, Rachel K. ;
Sainz, Alva G. ;
Singh, Neha ;
Desai, Ankit A. ;
Kraft, Andrew S. ;
Warfel, Noel A. .
CLINICAL CANCER RESEARCH, 2018, 24 (01) :169-180
[8]   Reversal of Lactate and PD-1-mediated Macrophage Immunosuppression Controls Growth of PTEN/p53-deficient Prostate Cancer [J].
Chaudagar, Kiranj ;
Hieromnimon, Hanna M. ;
Khurana, Rimpi ;
Labadie, Brian ;
Hirz, Taghreed ;
Mei, Shenglin ;
Hasan, Raisa ;
Shafran, Jordan ;
Kelley, Anne ;
Apostolov, Eva ;
Al-Eryani, Ghamdan ;
Harvey, Kate ;
Rameshbabu, Srikrishnan ;
Loyd, Mayme ;
Bynoe, Kaela ;
Drovetsky, Catherine ;
Solanki, Ani ;
Markiewicz, Erica ;
Zamora, Marta ;
Fan, Xiaobin ;
Schuer, Stephan ;
Swarbrick, Alex ;
Sykes, David B. ;
Patnaik, Akash .
CLINICAL CANCER RESEARCH, 2023, 29 (10) :1952-1968
[9]   SIRT5 Directly Inhibits the PI3K/AKT Pathway in Prostate Cancer Cell Lines [J].
Choi, So Young ;
Jeon, Ju Mi ;
Na, Ann Yae ;
Kwon, Oh Kwang ;
Bang, In Hyuk ;
Ha, Yun-Sok ;
Bae, Eun Ju ;
Park, Byung-Hyun ;
Lee, Eun Hye ;
Kwon, Tae Gyun ;
Lee, Jun Nyung ;
Lee, Sangkyu .
CANCER GENOMICS & PROTEOMICS, 2022, 19 (01) :50-59
[10]   Fatty Acid Inhibition Sensitizes Androgen-Dependent and -Independent Prostate Cancer to Radiotherapy via FASN/NF-κB Pathway [J].
Chuang, Hui-Yen ;
Lee, Yen-Po ;
Lin, Wei-Chan ;
Lin, Yi-Hsien ;
Hwang, Jeng-Jong .
SCIENTIFIC REPORTS, 2019, 9 (1)